Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M606728200 on December 6, 2006

J. Biol. Chem., Vol. 282, Issue 7, 4253-4264, February 16, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/7/4253    most recent
M606728200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaileh, M.
Right arrow Articles by Haegeman, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaileh, M.
Right arrow Articles by Haegeman, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Withaferin A Strongly Elicits I{kappa}B Kinase beta Hyperphosphorylation Concomitant with Potent Inhibition of Its Kinase Activity*Formula

Mary Kaileh{ddagger}§1, Wim Vanden Berghe{ddagger}2, Arne Heyerick, Julie Horion||, Jacques Piette||, Claude Libert**, Denis De Keukeleire, Tamer Essawi§, and Guy Haegeman{ddagger}3

From the {ddagger}Laboratory of Eukaryotic Gene Expression and Signal Transduction (LEGEST), Department of Molecular Biology, Ghent University-UGent, K. L. Ledeganckstraat 35, B-9000 Gent, Belgium, §Master program in Clinical Laboratory Sciences, Birzeit University, P. O. Box 14, Birzeit, Palestine, ||Center for Biomedical Integrated Genoproteomics (CBIG), Virology and Immunology Unit, Institute of Pathology B23, B-4000 Liege, Belgium, **Department of Molecular Biomedical Research, Flanders Interuniversity for Biotechnology and Ghent University, Technologiepark 927, B-9052 Zwijnaarde, Belgium, and Laboratory of Pharmacognosy and Phytochemistry, Ghent University-UGent, Harelbekestraat 72, B-9000 Gent, Belgium

The transcription factor NF{kappa}B plays a critical role in normal and pathophysiological immune responses. Therefore, NF{kappa}B and the signaling pathways that regulate its activation have become a major focus of drug development programs. Withania somnifera (WS) is a medicinal plant that is widely used in Palestine for the treatment of various inflammatory disorders. In this study we show that the leave extract of WS, as well as its major constituent withaferin A (WA), potently inhibits NF{kappa}B activation by preventing the tumor necrosis factor-induced activation of I{kappa}B kinase beta via a thioalkylation-sensitive redox mechanism, whereas other WS-derived steroidal lactones, such as withanolide A and 12-deoxywithastramonolide, are far less effective. To our knowledge, this is the first communication of I{kappa}B kinase beta inhibition by a plant-derived inhibitor, coinciding with MEK1/ERK-dependent Ser-181 hyperphosphorylation. This prevents I{kappa}B phosphorylation and degradation, which subsequently blocks NF{kappa}B translocation, NF{kappa}B/DNA binding, and gene transcription. Taken together, our results indicate that pure WA or WA-enriched WS extracts can be considered as a novel class of NF{kappa}B inhibitors, which hold promise as novel anti-inflammatory agents for treatment of various inflammatory disorders and/or cancer.


Received for publication, July 14, 2006 , and in revised form, December 6, 2006.

* This work was supported in part by grants from Interuniversitaire Attractiepolen V and from Geconcerteerde Onderzoeksacties. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.

1 Supported by Belgian technical cooperation and L’OREAL-United Nations Educational, Scientific, and Cultural Organization for women in science fellowships.

2 A postdoctoral fellow with the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen.

3 To whom correspondence should be addressed. Tel.: 003292645166; Fax: 003292645304; E-mail: Guy.Haegeman{at}UGent.be.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M.-R. Pan, H.-C. Chang, Y.-C. Wu, C.-C. Huang, and W.-C. Hung
Tubocapsanolide A Inhibits Transforming Growth Factor-{beta}-activating Kinase 1 to Suppress NF-{kappa}B-induced CCR7
J. Biol. Chem., January 30, 2009; 284(5): 2746 - 2754.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Schwarzer, Z. Fu, H. Fischer, and T. E. Machen
Redox-independent Activation of NF-{kappa}B by Pseudomonas aeruginosa Pyocyanin in a Cystic Fibrosis Airway Epithelial Cell Line
J. Biol. Chem., October 3, 2008; 283(40): 27144 - 27153.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. D. Stan, E.-R. Hahm, R. Warin, and S. V. Singh
Withaferin A Causes FOXO3a- and Bim-Dependent Apoptosis and Inhibits Growth of Human Breast Cancer Cells In vivo
Cancer Res., September 15, 2008; 68(18): 7661 - 7669.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. K. Pandey, B. Sung, A. B. Kunnumakkara, G. Sethi, M. M. Chaturvedi, and B. B. Aggarwal
Berberine Modifies Cysteine 179 of I{kappa}B{alpha} Kinase, Suppresses Nuclear Factor-{kappa}B-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis
Cancer Res., July 1, 2008; 68(13): 5370 - 5379.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H.-C. Chang, F.-R. Chang, Y.-C. Wang, M.-R. Pan, W.-C. Hung, and Y.-C. Wu
A bioactive withanolide Tubocapsanolide A inhibits proliferation of human lung cancer cells via repressing Skp2 expression
Mol. Cancer Ther., May 1, 2007; 6(5): 1572 - 1578.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement